Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT01985477 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Terminated Phase I due to slow accrual without progression to Phase II.

Conditions

Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: All-Trans Retinoic Acid (ATRA)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]